oxotremorine has been researched along with Parkinsonian Disorders in 3 studies
Oxotremorine: A non-hydrolyzed muscarinic agonist used as a research tool.
Parkinsonian Disorders: A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.
Excerpt | Relevance | Reference |
---|---|---|
" Assessment of the effects of chronic administration of Diol (20mg/kg) and L-DOPA to animals with 6-OHDA-induced PS showed that administration of Diol alleviated the symptoms of sensorimotor deficit in right limbs in rats." | 1.46 | Evolution of anti-parkinsonian activity of monoterpenoid (1R,2R,6S)-3-methyl-6-(prop-1-en-2-yl)cyclohex-3-ene-1,2-diol in various in vivo models. ( Ardashov, O; Ivanova, Е; Kapitsa, I; Khazanov, V; Salakhutdinov, N; Valdman, E; Volcho, K; Voronina, TI, 2017) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Valdman, E | 1 |
Kapitsa, I | 1 |
Ivanova, Е | 1 |
Voronina, TI | 1 |
Ardashov, O | 1 |
Volcho, K | 1 |
Khazanov, V | 1 |
Salakhutdinov, N | 1 |
ARCHIBALD, JL | 1 |
Hegab, MI | 1 |
Abdulla, MM | 1 |
3 other studies available for oxotremorine and Parkinsonian Disorders
Article | Year |
---|---|
Evolution of anti-parkinsonian activity of monoterpenoid (1R,2R,6S)-3-methyl-6-(prop-1-en-2-yl)cyclohex-3-ene-1,2-diol in various in vivo models.
Topics: Animals; Antiparkinson Agents; Catalepsy; Cyclohexanols; Disease Models, Animal; Male; Mice; Mice, I | 2017 |
IMPROVED SYNTHESIS OF OXOTREMORINE.
Topics: Chemistry, Pharmaceutical; Oxotremorine; Parasympatholytics; Parkinsonian Disorders; Pyrroles; Resea | 1965 |
4-Chloro-2,2-disubstituted chromen-3-carboxaldehyde: synthesis of some fused polycyclic heterocycles as anti-inflammatory, analgesic, anticonvulsant, and antiparkinsonian agents.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Anticonvulsants; Antiparkinson Agents; Benzopyrans; C | 2006 |